FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1773341657> ?p ?o ?g. }

• W1773341657 abstract "Histone deacetylases (HDACs) and the phosphatidylinositol 3-kinase (PI3K)/AKT pathway are promising therapeutic targets in hematologic cancers and evidence of synergistic anti-cancer activity has recently emerged. CUDC-907, a small molecule drug candidate that is designed to target HDACs and PI3Ks in a single chemical entity, is currently in Phase 1 clinical testing for the treatment of patients with lymphoma or multiple myeloma. Preclinically, CUDC-907 has been shown to inhibit activation of PI3K/AKT, JAK/STAT and MAPK pathways in hematologic cancer cell lines such as Hodgkin9s lymphoma, diffuse large B-cell lymphoma, and multiple myeloma. In this study, we report that in the setting of hematological malignancies, CUDC-907 targets not only the cancer cells but also the tumor microenvironment. Cytotoxicity against primary CLL cells was independent of the protective effects provided by stromal cells when primary CLL cells were co-cultured with nurse-like cells. CUDC-907 was shown in vitro to impair cytokine and chemokine production by immune cells in the tumor microenvironment and by Hodgkin9s lymphoma cells. The ongoing first-in-human Phase 1 clinical study of CUDC-907 has yielded preliminary evidence of anti-cancer activity and impact on the tumor microenvironment as measured by cytokine and chemokine levels (e.g., thymus and activation regulated chemokine [TARC]). Ongoing analyses are probing the potential utility of selected cytokine and chemokine as predictive markers of CUDC-907 activity. Citation Format: Anna W. Ma, Ruzanna Atoyan, Anas Younes, Ian W. Flinn, Yasuhiro Oki, Amanda Copeland, Jesus G. Berdeja, Robert Laliberte, Jaye Viner, Maria Elena S. Samson, Steven Dellarocca, Ling Yi, Mylissa Borek, Brian Zifcak, Guangxin Xu, Jing Wang. Dual function HDAC and PI3K inhibitor, CUDC-907 affects cancer cells and the tumor microenvironment in hematological malignancies. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1879. doi:10.1158/1538-7445.AM2014-1879" @default.
• W1773341657 created "2016-06-24" @default.
• W1773341657 creator A5000959540 @default.
• W1773341657 creator A5002541288 @default.
• W1773341657 creator A5008871439 @default.
• W1773341657 creator A5021430704 @default.
• W1773341657 creator A5037677450 @default.
• W1773341657 creator A5037784199 @default.
• W1773341657 creator A5041533942 @default.
• W1773341657 creator A5044444117 @default.
• W1773341657 creator A5048966000 @default.
• W1773341657 creator A5050961257 @default.
• W1773341657 creator A5054397662 @default.
• W1773341657 creator A5065054247 @default.
• W1773341657 creator A5065104224 @default.
• W1773341657 creator A5068152076 @default.
• W1773341657 creator A5080636708 @default.
• W1773341657 creator A5089802322 @default.
• W1773341657 date "2014-09-30" @default.
• W1773341657 modified "2023-09-30" @default.
• W1773341657 title "Abstract 1879: Dual function HDAC and PI3K inhibitor, CUDC-907 affects cancer cells and the tumor microenvironment in hematological malignancies" @default.
• W1773341657 doi "https://doi.org/10.1158/1538-7445.am2014-1879" @default.
• W1773341657 hasPublicationYear "2014" @default.
• W1773341657 type Work @default.
• W1773341657 sameAs 1773341657 @default.
• W1773341657 citedByCount "2" @default.
• W1773341657 countsByYear W17733416572015 @default.
• W1773341657 countsByYear W17733416572017 @default.
• W1773341657 crossrefType "proceedings-article" @default.
• W1773341657 hasAuthorship W1773341657A5000959540 @default.
• W1773341657 hasAuthorship W1773341657A5002541288 @default.
• W1773341657 hasAuthorship W1773341657A5008871439 @default.
• W1773341657 hasAuthorship W1773341657A5021430704 @default.
• W1773341657 hasAuthorship W1773341657A5037677450 @default.
• W1773341657 hasAuthorship W1773341657A5037784199 @default.
• W1773341657 hasAuthorship W1773341657A5041533942 @default.
• W1773341657 hasAuthorship W1773341657A5044444117 @default.
• W1773341657 hasAuthorship W1773341657A5048966000 @default.
• W1773341657 hasAuthorship W1773341657A5050961257 @default.
• W1773341657 hasAuthorship W1773341657A5054397662 @default.
• W1773341657 hasAuthorship W1773341657A5065054247 @default.
• W1773341657 hasAuthorship W1773341657A5065104224 @default.
• W1773341657 hasAuthorship W1773341657A5068152076 @default.
• W1773341657 hasAuthorship W1773341657A5080636708 @default.
• W1773341657 hasAuthorship W1773341657A5089802322 @default.
• W1773341657 hasConcept C121608353 @default.
• W1773341657 hasConcept C126322002 @default.
• W1773341657 hasConcept C13373296 @default.
• W1773341657 hasConcept C16930146 @default.
• W1773341657 hasConcept C203014093 @default.
• W1773341657 hasConcept C2776107976 @default.
• W1773341657 hasConcept C2776364478 @default.
• W1773341657 hasConcept C2778690821 @default.
• W1773341657 hasConcept C2779338263 @default.
• W1773341657 hasConcept C502942594 @default.
• W1773341657 hasConcept C62478195 @default.
• W1773341657 hasConcept C71924100 @default.
• W1773341657 hasConcept C86554907 @default.
• W1773341657 hasConcept C86803240 @default.
• W1773341657 hasConcept C8891405 @default.
• W1773341657 hasConcept C95444343 @default.
• W1773341657 hasConcept C96232424 @default.
• W1773341657 hasConceptScore W1773341657C121608353 @default.
• W1773341657 hasConceptScore W1773341657C126322002 @default.
• W1773341657 hasConceptScore W1773341657C13373296 @default.
• W1773341657 hasConceptScore W1773341657C16930146 @default.
• W1773341657 hasConceptScore W1773341657C203014093 @default.
• W1773341657 hasConceptScore W1773341657C2776107976 @default.
• W1773341657 hasConceptScore W1773341657C2776364478 @default.
• W1773341657 hasConceptScore W1773341657C2778690821 @default.
• W1773341657 hasConceptScore W1773341657C2779338263 @default.
• W1773341657 hasConceptScore W1773341657C502942594 @default.
• W1773341657 hasConceptScore W1773341657C62478195 @default.
• W1773341657 hasConceptScore W1773341657C71924100 @default.
• W1773341657 hasConceptScore W1773341657C86554907 @default.
• W1773341657 hasConceptScore W1773341657C86803240 @default.
• W1773341657 hasConceptScore W1773341657C8891405 @default.
• W1773341657 hasConceptScore W1773341657C95444343 @default.
• W1773341657 hasConceptScore W1773341657C96232424 @default.
• W1773341657 hasLocation W17733416571 @default.
• W1773341657 hasOpenAccess W1773341657 @default.
• W1773341657 hasPrimaryLocation W17733416571 @default.
• W1773341657 hasRelatedWork W1501473694 @default.
• W1773341657 hasRelatedWork W1549139917 @default.
• W1773341657 hasRelatedWork W1565438444 @default.
• W1773341657 hasRelatedWork W1923506036 @default.
• W1773341657 hasRelatedWork W1997251655 @default.
• W1773341657 hasRelatedWork W2086285137 @default.
• W1773341657 hasRelatedWork W2153162429 @default.
• W1773341657 hasRelatedWork W2295722228 @default.
• W1773341657 hasRelatedWork W2477005914 @default.
• W1773341657 hasRelatedWork W2486455593 @default.
• W1773341657 hasRelatedWork W2520255077 @default.
• W1773341657 hasRelatedWork W2565569852 @default.
• W1773341657 hasRelatedWork W2621935633 @default.
• W1773341657 hasRelatedWork W2665803427 @default.
• W1773341657 hasRelatedWork W2740234219 @default.
• W1773341657 hasRelatedWork W2740312590 @default.
• W1773341657 hasRelatedWork W2741536934 @default.
• W1773341657 hasRelatedWork W2793770674 @default.

• next